APTAMER GROUP

Transforming discovery with next-generation aptamer technology

Aptamer Group is a UK-based biotechnology company developing advanced nucleic acid aptamers—high-performance synthetic binders that offer a powerful alternative to antibodies across research, diagnostics, and therapeutics.

Using their proprietary parallel discovery platform, Aptamer Group designs and selects oligonucleotide aptamers that bind with exceptional specificity and affinity to a wide range of targets, from small molecules and peptides to complex structures such as viruses, whole cells, and tissues.

The resulting aptamers can be rapidly optimized and tailored for diverse applications, enabling more predictable, robust, and scalable solutions compared to traditional binders. Aptamer Group’s technology accelerates discovery and delivers reliable, high-quality tools for life science innovators worldwide.

More information: www.aptamergroup.com